Variables | Control group (N = 36) | CI group (N = 71) | PIB group (N = 73) | F/χ2 value | p |
---|---|---|---|---|---|
Age(years) | 65.75 ± 8.62 | 64.90 ± 7.77 | 65.90 ± 7.49 | 0.091 | 0.913 |
Male sex, n (%) | 23 (63.9%) | 39 (54.9%) | 43 (58.9%) | 0.417 | 0.812 |
BMI | 27.10 ± 2.84 | 26.81 ± 2.76 | 27.84 ± 3.16 | 0.664 | 0.518 |
ASA classification, n (%) | Â | Â | Â | 1.173 | 0.883 |
I | 6 (16.7%) | 14 (19.7%) | 18 (24.7%) | Â | Â |
II | 24 (66.7%) | 46 (64.8%) | 43 (58.9%) | Â | Â |
III | 6 (16.7%) | 11 (15.5%) | 12 (16.4%) | Â | Â |
Smoking history, n (%) | 7 (16.7%) | 17 (23.9%) | 16 (21.6%) | 0.749 | 0.688 |
COPD, n (%) | 4 (11.1%) | 8 (11.3%) | 10 (13.7%) | 0.250 | 0.882 |
Hypertension, n (%) | 8 (22.2%) | 20 (28.2%) | 17 (23.3%) | 0.643 | 0.725 |
Diabetes, n (%) | 7 (19.4%) | 15 (21.1%) | 18 (24.7%) | 0.460 | 0.794 |
Coronary heart disease, n (%) | 11 (30.6%) | 22 (31.0%) | 20 (27.4%) | 0.250 | 0.883 |
TNM classification, n (%) | Â | Â | Â | 0.532 | 0.970 |
I | 14 (38.9%) | 30 (42.3%) | 33 (45.2%) | Â | Â |
II | 12 (33.3%) | 22 (31.0%) | 23 (31.5%) | Â | Â |
III | 10 (27.8%) | 19 (26.8%) | 17 (23.2%) | Â | Â |
Intraoperative data | Â | Â | Â | Â | Â |
Propofol consumption (ug) | 1155.50 ± 128.41 | 1166.50 ± 141.62 | 1134.50 ± 186.53 | 0.222 | 0.801 |
Intraoperative fluid blood loss (ml) | 2070.00 ± 290.37 | 2055.00 ± 337.91 | 1965.00 ± 313.34 | 0.652 | 0.525 |
Surgery time (min) | 124.38 ± 25.95 | 119.88 ± 24.91 | 124.63 ± 28.66 | 0.203 | 0.817 |